← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Mercator Medsystems, Inc.
San Leandro, CA
$9,059,900
Total funding
7
Grants
Funding over time
peak $2.6M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,059,900 · 7
By mechanism
R44$6,780,654 · 2
R42$1,352,604 · 1
R41$517,733 · 2
R43$408,909 · 2
Investigators at Mercator Medsystems, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Preventing Post-Thrombotic Syndrome after Deep Vein Thrombosis with Perivascular Anti-Inflammatory Agent Delivery$1,636,379
R44 · FY2024 · HL
Preventing Post-Thrombotic Syndrome after Deep Vein Thrombosis with Perivascular Anti-Inflammatory Agent Delivery$1,095,555
R44 · FY2025 · HL
Improved Adventitial Rapamycin Therapy for Peripheral Artery Restenosis$1,088,602
R44 · FY2014 · HL
Improved Sirolimus-Analog Adventitial Delivery to Enhance Outcomes in Below-the-Knee Peripheral Artery Disease$1,000,000
R44 · FY2025 · HL
Improved Sirolimus-Analog Adventitial Delivery to Enhance Outcomes in Below-the-Knee Peripheral Artery Disease$1,000,000
R44 · FY2024 · HL
Improved Adventitial Rapamycin Therapy for Peripheral Artery Restenosis$960,118
R44 · FY2013 · HL
Broncho-adventitial Drug Delivery: Paclitaxel for Bronchial Carcinoma$676,092
R42 · FY2011 · CA
Broncho-adventitial Drug Delivery: Paclitaxel for Bronchial Carcinoma$463,075
R42 · FY2012 · CA
Preventing Post-Thrombotic Syndrome after Deep Vein Thrombosis with Perivascular Anti-Inflammatory Agent Delivery$299,678
R41 · FY2021 · HL
Bronchio-adventitial Drug Delivery: Paclitaxel for Bronchial Carcinoma$218,055
R41 · FY2009 · CA
Improved Adventitial Sirolimus Therapy for Peripheral Artery Restenosis$217,409
R43 · FY2010 · HL
Broncho-adventitial Drug Delivery: Paclitaxel for Bronchial Carcinoma$213,437
R42 · FY2013 · CA
Adventitial Paclitaxel to Delay Post-Intervention Dialysis Graft Stenosis$191,500
R43 · FY2007 · DK